ACT vs CQ With Tafenoquine for P. Vivax Mono-infection
ACT vs CQ With Tafenoquine for P. Vivax Mono-infection
Recruiting · NCT05788094 · Registry updated 2025-05-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ACT vs CQ With Tafenoquine for P. Vivax Mono-infection | Infections, Mosquito-Borne Diseases, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 4 | 2025-05-16 | NCT05788094 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mahidol Oxford Tropical Medicine Research Unit | 5 |
| Shoklo Malaria Research Unit | 2 |
| University of Oxford | 213 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shoklo Malaria Research Unit (SMRU) | Mae Sot | Thailand | 1 |